Effect of Visually-Guided Gait Training on Balance, Mobility and Risk of Falling in Patients With Multiple Sclerosis
1 other identifier
interventional
40
1 country
1
Brief Summary
The aim of this study is to assess both immediate and long-term effects of visually-guided gait training on balance, mobility, and risk of falling in patients with multiple sclerosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable multiple-sclerosis
Started Nov 2025
Shorter than P25 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 14, 2025
CompletedFirst Posted
Study publicly available on registry
November 18, 2025
CompletedStudy Start
First participant enrolled
November 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 20, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2026
CompletedDecember 22, 2025
November 1, 2025
5 months
November 14, 2025
December 16, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Dynamic Balance Performance (%):
The percentage score representing how accurately the participant maintained the red spot path within the designated frame during the dynamic balance test. A higher percentage indicates better balance control and greater stability.
8 weeks and follow up after 4 weeks.
Front Average Deviation
The mean displacement of the participant's center of pressure (COP) in the forward (anterior) direction.
8 weeks and follow up after 4 weeks
Back Average Deviation
The mean displacement of the participant's center of pressure (COP) in the backward (posterior) direction.
8 weeks and follow up after 4 weeks
Right Average Deviation
The mean displacement of the participant's center of pressure (COP) in the right (lateral) direction.
8 weeks and follow up after 4 weeks
Left Average Deviation
The mean displacement of the participant's center of pressure (COP) in the left (lateral) direction.
8 weeks and follow up after 4 weeks
Secondary Outcomes (3)
The Four-Square Step Test (FSST)
8 weeks and follow up after 4 weeks
The Ten-Meter Walk Test (10MWT)
8 weeks and follow up after 4 weeks
Arabic version of Falls Efficacy Scale-International (FES-I)
8 weeks and follow up after 4 weeks
Study Arms (2)
Visually-guided gait training + Conventional gait training
EXPERIMENTALThis group will consist of twenty patients, who will receive visually-guided gait training and conventional gait training for 8 weeks.
Conventional gait training
ACTIVE COMPARATORThis group will consist of twenty patients, who will receive conventional gait training only for 8 weeks.
Interventions
The program runs for eight weeks, with two 60-minute sessions per week, integrating gaze strategy, task-specific mobility, and dual-task cognitive training. Participants first learn systematic visual scanning using saccades and gridline searches. In task-specific training, they perform precision walking-stepping accurately on targets-and obstacle avoidance, navigating a 6 m path with variable pole positions to enhance visual-motor coordination. Finally, dual-task training adds cognitive challenges, such as word generation or backward counting, to improve attention, adaptability, and functional mobility.
It will be received for eight weeks, twice per week, each session lasting 30 minutes, consisting of standing and walking activities maintaining a stable base of support; static postural control exercises, weight shifting and perturbations exercises, weight-bearing exercises through lower limbs; and adequate weight transfer and forward progression with trunk, limb, and pelvic kinematics consistent with safe walking, walking forward and backward, side-stepping, standing and walking on varied surfaces.
Eligibility Criteria
You may qualify if:
- Clinically definite MS (relapsing and remitting) patients who are stable for at least three months.
- Expanded Disability Status Scale (EDSS) score of ≤ 4 (fully ambulatory, self-sufficient, and able to stand and walk without any aid or orthosis at least 500 meters) to minimize the impact of motor weakness interfering with their ability to perform the task.
- Normal or corrected to normal vision, wearing eyeglasses.
- The age will range from 20 - 45 years.
- All patients with MS were required to report subjective perceived imbalance or history of falls (in the last year)
You may not qualify if:
- Patients with any other neurological deficits or orthopedics abnormalities.
- Patients with secondary musculoskeletal complications such as fractures, contractures, or deformities.
- Patients with vision problems that impaired walking ability.
- Patients with severe cognitive impairment or psychological disorders impaired the ability to follow the procedures of the study.
- Patients with cardiovascular and respiratory diseases.
- Patients with serious unstable medical condition or Patients had an acute exacerbation of MS within last month.
- Pregnant women.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Kafrelsheikh University Hospital
Kafr ash Shaykh, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Abeer Abo Bakr, PhD
Professor, Cairo university
- STUDY DIRECTOR
Ibrahim Hamoda, PhD
Assistant professor, Kafr Elsheikh univeristy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 14, 2025
First Posted
November 18, 2025
Study Start
November 30, 2025
Primary Completion
April 20, 2026
Study Completion
April 30, 2026
Last Updated
December 22, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share